Adult bronchiolitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Adult bronchiolitis}} | {{Adult bronchiolitis}} | ||
{{CMG}};{{AE}}{{HM}} | {{CMG}};{{AE}}{{HM}} | ||
==Overview== | |||
The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 3 per 100,000 of all [[Community-acquired pneumonia|community acquired pneumonias]] have underlying [[bronchiolitis]]. The prevalence of adult-onset bronchiolitis is unknown. The most common cause of [[bronchiolitis]] in adults is RSV, most adults tend to be asymptomatic or carriers and therefore, prevalence is difficult to stipulate. The attack rate for death caused by [[bronchiolitis]] complicated by [[pneumonia]] in elderly homes is approximately 3 per 100,000. The incidence of adult bronchiolitis increases with age; the median age at diagnosis is 68 years. There is no racial predilection in adults. Men are more commonly affected by bronchiolitis than women, and tend to have higher mortality rates. Diffuse panbronchiolitis is a common disease that tends to affect Japan. Those of Hispanic, Native American and Alaskan origins tend to have a higher likelihood of hospitalization. Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA | The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 3 per 100,000 of all [[Community-acquired pneumonia|community acquired pneumonias]] have underlying bronchiolitis.<ref name="pmid10885982">{{cite journal |vauthors=Falsey AR, Walsh EE |title=Respiratory syncytial virus infection in adults |journal=Clin. Microbiol. Rev. |volume=13 |issue=3 |pages=371–84 |date=July 2000 |pmid=10885982 |pmc=88938 |doi= |url=}}</ref><ref name="pmid26524622">{{cite journal |vauthors=Ryu K, Takayanagi N, Ishiguro T, Kanauchi T, Kawate E, Kagiyama N, Sugita Y |title=Etiology and Outcome of Diffuse Acute Infectious Bronchiolitis in Adults |journal=Ann Am Thorac Soc |volume=12 |issue=12 |pages=1781–7 |date=December 2015 |pmid=26524622 |doi=10.1513/AnnalsATS.201507-473OC |url=}}</ref><ref name="pmid14670770">{{cite journal |vauthors=Deshpande SA, Northern V |title=The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area |journal=Arch. Dis. Child. |volume=88 |issue=12 |pages=1065–9 |date=December 2003 |pmid=14670770 |pmc=1719378 |doi= |url=}}</ref><ref name="pmid28689664">{{cite journal |vauthors=Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H |title=Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study |journal=Lancet |volume=390 |issue=10098 |pages=946–958 |date=September 2017 |pmid=28689664 |pmc=5592248 |doi=10.1016/S0140-6736(17)30938-8 |url=}}</ref><ref name="pmid25349312">{{cite journal |vauthors=Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S, Hernandez-Cancio S |title=Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis |journal=Pediatrics |volume=134 |issue=5 |pages=e1474–502 |date=November 2014 |pmid=25349312 |doi=10.1542/peds.2014-2742 |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
| Line 12: | Line 16: | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
The attack rate for death caused by bronchiolitis complicated by pneumonia in elderly homes is approximately | The attack rate for death caused by [[bronchiolitis]] complicated by [[pneumonia]] in elderly homes is approximately 3 per 100,000. | ||
===Age=== | ===Age=== | ||
| Line 28: | Line 32: | ||
===Developed Countries vs. Developing Countries=== | ===Developed Countries vs. Developing Countries=== | ||
Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates. | Developed and developing countries tend to have similar [[incidence]], hospitalisation and [[Mortality rate|mortality rates]]. | ||
Latest revision as of 13:29, 5 April 2018
|
Adult bronchiolitis Microchapters |
|
Differentiating Occupational lung disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adult bronchiolitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adult bronchiolitis epidemiology and demographics |
|
Adult bronchiolitis epidemiology and demographics in the news |
|
|
|
Risk calculators and risk factors for Adult bronchiolitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 3 per 100,000 of all community acquired pneumonias have underlying bronchiolitis. The prevalence of adult-onset bronchiolitis is unknown. The most common cause of bronchiolitis in adults is RSV, most adults tend to be asymptomatic or carriers and therefore, prevalence is difficult to stipulate. The attack rate for death caused by bronchiolitis complicated by pneumonia in elderly homes is approximately 3 per 100,000. The incidence of adult bronchiolitis increases with age; the median age at diagnosis is 68 years. There is no racial predilection in adults. Men are more commonly affected by bronchiolitis than women, and tend to have higher mortality rates. Diffuse panbronchiolitis is a common disease that tends to affect Japan. Those of Hispanic, Native American and Alaskan origins tend to have a higher likelihood of hospitalization. Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates.
Epidemiology and Demographics
Incidence
The incidence for adult bronchiolitis is not well recorded, it is estimated that in the USA 3 per 100,000 of all community acquired pneumonias have underlying bronchiolitis.[1][2][3][4][5]
Prevalence
- The prevalence of adult-onset bronchiolitis is unknown.
- The most common cause of bronchiolitis in adults is RSV, most adults tend to be asymptomatic or carriers and therefore, prevalence is difficult to stipulate.
Case-fatality rate/Mortality rate
The attack rate for death caused by bronchiolitis complicated by pneumonia in elderly homes is approximately 3 per 100,000.
Age
The incidence of adult bronchiolitis increases with age; the median age at diagnosis is 68 years.
Race
There is no racial predilection in adults.
Gender
Men are more commonly affected by bronchiolitis than women, and tend to have higher mortality rates.
Region
- Diffuse panbronchiolitis is a common disease that tends to affect Japan.
- Those of Hispanic, Native American and Alaskan origins tend to have a higher likelihood of hospitalization.
Developed Countries vs. Developing Countries
Developed and developing countries tend to have similar incidence, hospitalisation and mortality rates.
References
- ↑ Falsey AR, Walsh EE (July 2000). "Respiratory syncytial virus infection in adults". Clin. Microbiol. Rev. 13 (3): 371–84. PMC 88938. PMID 10885982.
- ↑ Ryu K, Takayanagi N, Ishiguro T, Kanauchi T, Kawate E, Kagiyama N, Sugita Y (December 2015). "Etiology and Outcome of Diffuse Acute Infectious Bronchiolitis in Adults". Ann Am Thorac Soc. 12 (12): 1781–7. doi:10.1513/AnnalsATS.201507-473OC. PMID 26524622.
- ↑ Deshpande SA, Northern V (December 2003). "The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area". Arch. Dis. Child. 88 (12): 1065–9. PMC 1719378. PMID 14670770.
- ↑ Shi T, McAllister DA, O'Brien KL, Simoes E, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie S, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott J, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H (September 2017). "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study". Lancet. 390 (10098): 946–958. doi:10.1016/S0140-6736(17)30938-8. PMC 5592248. PMID 28689664. Vancouver style error: initials (help)
- ↑ Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, Phelan KJ, Zorc JJ, Stanko-Lopp D, Brown MA, Nathanson I, Rosenblum E, Sayles S, Hernandez-Cancio S (November 2014). "Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis". Pediatrics. 134 (5): e1474–502. doi:10.1542/peds.2014-2742. PMID 25349312.